Transaction · 0001674236-26-000006

CAREY STEPHEN P.

CAREY STEPHEN P., SVP, CFO, reported a transaction classified as grant at ANI PHARMACEUTICALS INC involving 22233.000000 shares for an estimated $1715275.95. Reported holdings after the transaction were 192316.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ASVP, CFO
ANIPANI PHARMACEUTICALS INC
Filing timeMar 02
Trade dateFeb 26, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$75.22
Pre-filing
1mo ago +7.0%1w ago +3.8%1d ago +1.4%
Returns since
7d -0.5%30d +1.0%90d +4.4%180d -2.3%1y -2.3%

ANIP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ANIP since 2026-03-02Filed 185 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001674236-26-000006
Common Stock
Transaction date
Feb 26, 2026
Filed Mar 02, 2026, 12:00 AM · 4d delay
Shares
22.2k sh
$7.71k per share
Estimated value
$171M
Computed from shares × price
Holdings after
192k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP & CFO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026.

  2. F2

    Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,079 shares of restricted stock, the grant of which was previously reported.

Original filing · 0001674236-26-000006
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ANIP